Cargando…

Amyotrophic lateral sclerosis: a clinical review

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting primarily the motor system, but in which extra‐motor manifestations are increasingly recognized. The loss of upper and lower motor neurons in the motor cortex, the brain stem nuclei and the anterior horn of the spinal cord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masrori, P., Van Damme, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	ALS and frontotemporal dementia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540334/ https://www.ncbi.nlm.nih.gov/pubmed/32526057 http://dx.doi.org/10.1111/ene.14393

Ejemplares similares

Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation
por: Masrori, Pegah, et al.
Publicado: (2022)

Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis
por: Dharmadasa, T., et al.
Publicado: (2020)

Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis
por: Ikenaka, Kensuke, et al.
Publicado: (2022)

Prevalence and determinants of language impairment in non‐demented amyotrophic lateral sclerosis patients
por: Solca, Federica, et al.
Publicado: (2022)

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis
por: Falzone, Yuri Matteo, et al.
Publicado: (2022)

Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study
por: Palumbo, Francesca, et al.
Publicado: (2022)

Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis
por: Chang, Jeryn, et al.
Publicado: (2022)

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
por: Beghi, Ettore, et al.
Publicado: (2022)

Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases
por: Ferraro, Pilar M., et al.
Publicado: (2022)

Distinct disease trajectories in frontotemporal dementia–motor neuron disease and behavioural variant frontotemporal dementia: A longitudinal study
por: Long, Zhe, et al.
Publicado: (2022)

Machine‐learning in motor neuron diseases: Prospects and pitfalls
por: Bede, Peter, et al.
Publicado: (2022)

Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis
por: De Schaepdryver, Maxim, et al.
Publicado: (2022)

Prion‐like propagation as a pathogenic principle in frontotemporal dementia
por: Hock, Eva‐Maria, et al.
Publicado: (2016)

Tau physiology and pathomechanisms in frontotemporal lobar degeneration
por: Bodea, Liviu‐Gabriel, et al.
Publicado: (2016)

Is disrupted sleep a risk factor for Alzheimer’s disease? Evidence from a two-sample Mendelian randomization analysis
por: Anderson, Emma L, et al.
Publicado: (2020)

Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis
por: Catanese, Alberto, et al.
Publicado: (2023)

Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis
por: Masrori, Pegah, et al.
Publicado: (2022)

A Systematic Review of Quality Dementia Clinical Guidelines for the Development of WHO’s Package of Interventions for Rehabilitation
por: Jeon, Yun-Hee, et al.
Publicado: (2022)

Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
por: Klingl, Yvonne E., et al.
Publicado: (2020)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

In-home dementia caregiving is associated with greater psychological burden and poorer mental health than out-of-home caregiving: a cross-sectional study
por: Brini, S., et al.
Publicado: (2021)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Clinimetric Evaluation of the Experienced Communication in Dementia Questionnaire
por: Olthof-Nefkens, Maria W L J, et al.
Publicado: (2021)

A novel prognostic score to assess the risk of progression in relapsing−remitting multiple sclerosis patients
por: Pisani, Anna Isabella, et al.
Publicado: (2021)

Group experiences of cognitive stimulation therapy (CST) in Tanzania: a qualitative study
por: Morrish, Jasmine, et al.
Publicado: (2021)

Residential distance from high-voltage overhead power lines and risk of Alzheimer’s dementia and Parkinson’s disease: a population-based case-control study in a metropolitan area of Northern Italy
por: Gervasi, Federico, et al.
Publicado: (2019)

Risk of dementia in patients with inflammatory bowel disease: a Danish population‐based study
por: Rønnow Sand, Jakob, et al.
Publicado: (2022)

Dementia and the Paradigm of the Camp: Thinking Beyond Giorgio Agamben’s Concept of “Bare Life”
por: Burke, Lucy
Publicado: (2019)

Polygenic risk scores for Alzheimer’s disease, and academic achievement, cognitive and behavioural measures in children from the general population
por: Korologou-Linden, Roxanna, et al.
Publicado: (2019)

Exploring the bidirectional associations between loneliness and cognitive functioning over 10 years: the English longitudinal study of ageing
por: Yin, Jiamin, et al.
Publicado: (2019)

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021)

Clinical Psychology and Amyotrophic Lateral Sclerosis
por: Pagnini, Francesco, et al.
Publicado: (2010)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Genetic variability in sporadic amyotrophic lateral sclerosis
por: Van Daele, Sien Hilde, et al.
Publicado: (2023)

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019)

A comprehensive review of amyotrophic lateral sclerosis
por: Zarei, Sara, et al.
Publicado: (2015)

Amyotrophic Lateral Sclerosis: A Diet Review
por: D’Antona, Salvatore, et al.
Publicado: (2021)

Juvenile Amyotrophic Lateral Sclerosis: A Review
por: Lehky, Tanya, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
por: Corcia, Philippe, et al.
Publicado: (2012)

Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
por: Rizzuti, Mafalda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_210afv82mlq07saec174ttdj50